|
Glycodelin
|
D12.776.780.426 |
|
|
Pityriasis Lichenoides
|
C17.800.859.575.650 |
|
|
Parapsoriasis
|
C17.800.859.575 |
|
|
Correctional Facilities
|
J03.220 |
|
|
Temporomandibular Joint Dysfunction Syndrome
|
C07.678.949 |
|
|
Temporomandibular Joint Disorders
|
C07.678 |
|
|
N-Myc Proto-Oncogene Protein
|
D12.776.930.127.092.625 |
|
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
|
D12.776.930.127.092 |
|
|
Retinal Rod Photoreceptor Cells
|
A11.671.650.850.625.670.650 |
|
|
Dementia, Vascular
|
C10.228.140.695.500 |
|
|
Miller Fisher Syndrome
|
C10.292.562.350 |
|
|
Chromogranin A
|
D12.776.631.199.249 |
|
|
Triploidy
|
G05.700.740.500 |
|
|
Electron Transport Complex II
|
D08.811.600.250.875.249 |
|
|
Ascorbate Peroxidases
|
D08.811.682.732.165 |
|
|
Cholinesterase Inhibitors
|
D002800 |
[Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.
] |
|
Neoplasms, Fibroepithelial
|
C04.557.470.625 |
|
|
Cholinesterase Reactivators
|
D002801 |
[Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates.
] |
|
Chondroblastoma
|
D002804 |
[A usually benign tumor composed of cells which arise from chondroblasts or their precursors and which tend to differentiate into cartilage cells. It occurs primarily in the epiphyses of adolescents. It is relatively rare and represents less than 2% of all primary bone tumors. The peak incidence is in the second decade of life; it is about twice as common in males as in females. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1846)
] |
|
Chondrocalcinosis
|
D002805 |
[Presence of CALCIUM PYROPHOSPHATE in the connective tissues such as the cartilaginous structures of joints. When accompanied by GOUT-like symptoms, it is referred to as pseudogout.
] |
